文献速递产科母胎医学

SARS-CoV-2感染孕妇的母体与围产结局

Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-21

这项多国回顾性队列研究纳入22国72中心388例单胎妊娠且实验室确诊SARS-CoV-2感染的孕妇,复合不良母体结局47/388(12.1%),ICU入住43例(11.1%),机械通气36例(9.3%),死亡3例(0.8%),垂直传播仅1/251(0.4%)。

要点

  • 复合不良母体结局发生率为12.1%(47/388),其中ICU入住11.1%、机械通气9.3%、死亡0.8%。
  • 266例已分娩者中早产(<37周)率26.3%(70/266),围产儿死亡率4.1%(11/266)。
  • 垂直传播率低,仅1/251(0.4%)新生儿RT-PCR阳性,其母亲在孕晚期检测阳性。

核心结论

  • 孕妇SARS-CoV-2感染与0.8%的母体死亡率相关,但ICU入住率达11.1%;垂直传播风险似乎可忽略。

研究设计与样本

  • 多国回顾性队列研究,纳入2020年2月1日至2020年4月30日欧洲、美国、南美洲、亚洲和澳大利亚22个国家72个中心的单胎妊娠且实验室确诊SARS-CoV-2感染的孕妇。
  • 确诊定义为鼻咽拭子实时逆转录聚合酶链反应(RT-PCR)检测阳性。
  • 共纳入388例单胎妊娠且鼻咽拭子RT-PCR检测SARS-CoV-2阳性的孕妇。

主要发现

  • 复合不良母体结局(包括ICU入住、机械通气及死亡)见于47/388(12.1%)孕妇。
  • 43例(11.1%)入住ICU,36例(9.3%)需机械通气,3例(0.8%)死亡。
  • 388例中122例(31.4%)在数据分析时仍妊娠;其余266例中,孕早期感染者31例中6例(19.4%)流产,3例(1.1%)终止妊娠,6例(2.3%)死产,251例(94.4%)活产。
  • 早产(<37周)率为26.3%(70/266);251例活产儿中69例(27.5%)入住新生儿ICU,5例(2.0%)新生儿死亡;总围产儿死亡率为4.1%(11/266)。
  • 仅1例(1/251,0.4%)新生儿RT-PCR检测SARS-CoV-2阳性,其母亲在孕晚期检测阳性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the maternal and perinatal outcomes of pregnancies affected by SARS-CoV-2 infection. METHODS: This was a multinational retrospective cohort study including women with a singleton pregnancy and laboratory-confirmed SARS-CoV-2 infection, conducted in 72 centers in 22 different countries in Europe, the USA, South America, Asia and Australia, between 1 February 2020 and 30 April 2020. Confirmed SARS-CoV-2 infection was defined as a positive result on real-time reverse-transcription polymerase chain reaction (RT-PCR) assay of nasopharyngeal swab specimens. The primary outcome was a composite measure of maternal mortality and morbidity, including admission to the intensive care unit (ICU), use of mechanical ventilation and death. RESULTS: In total, 388 women with a singleton pregnancy tested positive for SARS-CoV-2 on RT-PCR of a nasopharyngeal swab and were included in the study. Composite adverse maternal outcome was observed in 47/388 (12.1%) women; 43 (11.1%) women were admitted to the ICU, 36 (9.3%) required mechanical ventilation and three (0.8%) died. Of the 388 women included in the study, 122 (31.4%) were still pregnant at the time of data analysis. Among the other 266 women, six (19.4% of the 31 women with first-trimester infection) had miscarriage, three (1.1%) had termination of pregnancy, six (2.3%) had stillbirth and 251 (94.4%) delivered a liveborn infant. The rate of preterm birth before 37 weeks' gestation was 26.3% (70/266). Of the 251 liveborn infants, 69/251 (27.5%) were admitted to the neonatal ICU, and there were five (2.0%) neonatal deaths. The overall rate of perinatal death was 4.1% (11/266). Only one (1/251, 0.4%) infant, born to a mother who tested positive during the third trimester, was found to be positive for SARS-CoV-2 on RT-PCR. CONCLUSIONS: SARS-CoV-2 infection in pregnant women is associated with a 0.8% rate of maternal mortality, but an 11.1% rate of admission to the ICU. The risk of vertical transmission seems to be negligible. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection. Ultrasound Obstet Gynecol. 2021. PMID: 32926494. doi:10.1002/uog.23107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。